DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)



company name or ticker

Investor Beat: Oct. 14

Check out the top business stories for today's investors. Today, we examine Netflix, Expedia, Antares Pharma, and others.

Why Antares Pharma Inc. Shares Temporarily Popped

Antares Pharma pops after receiving a thumbs-up from the Food and Drug Administration, but are shares now overvalued?

Mid-Day Market Update: US Stocks Pare Losses; Expedia Shares Drop Following Downgrade

Mid-Day Market Update: US Stocks Pare Losses; Expedia Shares Drop Following Downgrade

Mid-Morning Market Update: Markets Open Lower; Facebook Acquires Onavo

Mid-Morning Market Update: Markets Open Lower; Facebook Acquires Onavo

Antares' Otrexup Approval Was Easy, Selling Drug Will be Hard

Antares Will Change RA Treatment With The Introduction Of Otrexup

5 BioPharmas With Near-Term Catalysts

Antares' Otrexup Ready For FDA Approval

See More Articles...